Your browser doesn't support javascript.
loading
Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic Cancer.
Jain, Aditi; Agostini, Lebaron C; McCarthy, Grace A; Chand, Saswati N; Ramirez, AnnJosette; Nevler, Avinoam; Cozzitorto, Joseph; Schultz, Christopher W; Lowder, Cinthya Yabar; Smith, Kate M; Waddell, Ian D; Raitses-Gurevich, Maria; Stossel, Chani; Gorman, Yulia Glick; Atias, Dikla; Yeo, Charles J; Winter, Jordan M; Olive, Kenneth P; Golan, Talia; Pishvaian, Michael J; Ogilvie, Donald; James, Dominic I; Jordan, Allan M; Brody, Jonathan R.
Afiliação
  • Jain A; The Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Agostini LC; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • McCarthy GA; The Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Chand SN; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Ramirez A; The Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Nevler A; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Cozzitorto J; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Schultz CW; The Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Lowder CY; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Smith KM; The Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Waddell ID; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Raitses-Gurevich M; The Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Stossel C; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Gorman YG; The Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Atias D; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Yeo CJ; The Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Winter JM; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Olive KP; Drug Discovery Unit, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.
  • Golan T; Drug Discovery Unit, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.
  • Pishvaian MJ; Oncology Institute, Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • Ogilvie D; Oncology Institute, Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • James DI; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Jordan AM; Oncology Institute, Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • Brody JR; Oncology Institute, Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
Cancer Res ; 79(17): 4491-4502, 2019 09 01.
Article em En | MEDLINE | ID: mdl-31273064

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Glicosídeo Hidrolases Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Glicosídeo Hidrolases Idioma: En Ano de publicação: 2019 Tipo de documento: Article